Heron Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.42
|
|
Average Rating
|
4.83
|
|
# Strong Buys
|
5
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.38
|
-0.38
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.50
|
-0.55
|
-0.05
|
-10.00%
|
|
2022-03-31
|
-0.48
|
-0.63
|
-0.15
|
-31.25%
|
|
2021-12-31
|
-0.58
|
-0.54
|
0.04
|
6.90%
|
|
2021-09-30
|
-0.61
|
-0.51
|
0.10
|
16.39%
|
|
2021-06-30
|
-0.55
|
-0.62
|
-0.07
|
-12.73%
|
|
2021-03-31
|
-0.57
|
-0.58
|
-0.01
|
-1.75%
|
|
2020-12-31
|
-0.65
|
-0.68
|
-0.03
|
-4.62%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.56
|
|
2021-12-31
|
-2.25
|
|
2020-12-31
|
-2.50
|
|
2019-12-31
|
-2.50
|
|
2018-12-31
|
-2.47
|
|
2017-12-31
|
-3.66
|
|
2016-12-31
|
-4.55
|
|
2015-12-31
|
-2.94
|
|
2014-12-31
|
-2.89
|
|
2013-12-31
|
-3.35
|
|
2012-12-31
|
-1.89
|
|
2011-12-31
|
-2.81
|
|
2010-12-31
|
-3.71
|
|
2009-12-31
|
-6.57
|
|
2008-12-31
|
-15.00
|
|
2007-12-31
|
-30.73
|
|
2006-12-31
|
16.57
|
|
2005-12-31
|
-26.15
|
|
2004-12-31
|
-32.15
|
|
2003-12-31
|
-16.84
|
|
2002-12-31
|
-14.12
|
|
2001-12-31
|
-9.68
|
|
2000-12-31
|
-11.20
|
|
1999-12-31
|
8.46
|
|
1998-12-31
|
8.11
|